On June 29, 2026, the Office of Inspector General (OIG) announced a nationwide analysis of antipsychotic drug use among Medicare beneficiaries in nursing homes. The agency wants to determine how often providers overuse these medications and prescribe them for residents with dementia. As outlined in the OIG’s Work Plan, it will evaluate prescribing patterns and identify opportunities to improve resident care. However, we all know the FDA has not approved antipsychotic medications to treat dementia. In fact, the FDA warns that these medications may increase the risk of death in this population.

The OIG has expressed concern about inappropriate antipsychotic use in nursing homes for many years. In some cases, providers prescribe these medications to manage behaviors for staff convenience rather than medical necessity. According to a March 2026 review summarized by Skilled Nursing News, surveyors identified inappropriate antipsychotic use during 40 nursing home inspections.

• Giving antipsychotics for non-harmful behaviors such as playing with dolls, staying in bed, or asking for help.
• Failing to adequately monitor residents for side effects or the ongoing need for the medication.
• Medical directors and pharmacists not preventing inappropriate use or recommending gradual dose reductions.
• Misdiagnosing residents with schizophrenia to justify antipsychotic use and improve quality measure ratings.

This is not a new topic for any of us. In fact, many nursing homes have already faced penalties related to inappropriate schizophrenia diagnoses used to support antipsychotic therapy. It is also important to remember that state and federal surveyors shared this information with the OIG. The OIG did not make these observations during its own inspections.

As this nationwide review moves forward, let’s keep the conversation balanced. Yes, some providers overuse antipsychotic medications or prescribe them when residents do not need them. However, many nursing homes consistently demonstrate appropriate antipsychotic drug use. They accomplish this through comprehensive assessments, gradual dose reductions, pharmacy reviews, medical director oversight, and careful documentation.

Ultimately, let’s not lose sight of our goal. We must provide quality care and maintain clear supporting documentation for every medication a resident receives.

Stay well and stay informed!